SARAH KERWIN: Open Payments
NPI 1891346656 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$429 in 20 payments from 9 companies in 2025. Trend: 2023 $381 · 2024 $260 · 2025 $429
Food & beverage: $429
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $102 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $71 |
| JAZZ PHARMACEUTICALS INC. | 3 | $70 |
| CSL Behring | 2 | $50 |
| Optinose US, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: NUCALA, NEFFY, XYWAV, DUPIXENT, Hizentra, Xhance, SPEVIGO, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
